$1 Million Removes Barriers to Increase Adult Immunizations

GSK plc today announced the recipients of the inaugural grant program of the COiMMUNITY Initiative, a multipronged effort to support the design of a more systematic, collaborative and equitable approach to helping increase adult immunization rates in the United States.

Grant recipients include but are not limited to the American Lung Association, American Pharmacists Association (APhA), APhA Foundation, Asian Health Coalition, Global Health Living Foundation, Immunize Kansas Coalition, Pharmacy Quality Alliance, and The Arizona Partnership for Immunization.

Each grant-funded project receives between $50,000 and $175,000 out of a total of $1 million to help address long-standing barriers to adult immunization in the U.S.

Rob Truckenmiller, Senior Vice President, Head of U.S. Vaccines, GSK, commented in a press release on December 12, 2023, "Getting ahead of vaccine-preventable disease starts by investing in organizations who know their communities best, and I can't think of a more deserving group of recipients for our first-ever COiMMUNITY Initiative grants."

"With these grants, our goal is to support innovative ways to encourage adult vaccination and help mitigate health inequities at both the local and national levels."

The organizations that received funding submitted proposals that demonstrated innovative, ambitious, and actionable ideas for boosting adult vaccination, such as building vaccine confidence among underserved patient populations through trusted community partners, creating engaging multilingual educational materials, and developing resources to support pharmacists and local health departments.

Through the COiMMUNITY Initiative, GSK will continue to build on its commitment to help support long-lasting solutions to address adult immunization challenges through ongoing investments to empower stakeholders with actionable data, models, and best practices in adult vaccine confidence and delivery.